Literature DB >> 27061225

The First Report of Bayés Syndrome in Hemodialysis Patient.

Marco Marano1, Anna D'Amato1, Alessandra Cantone2.   

Abstract

A chronic hemodialysis patient-known to have advanced interatrial block (IAB)-had reported symptoms suggesting arrhythmias, hence she underwent hemodialysis treatment while on the cardiac monitor. This allowed us to recognize the occurrence of paroxysmal atrial fibrillation and, in turn, disclose the first case of Bayés syndrome. Even though atrial fibrillation and IAB are very frequent in hemodialysis patients, Bayés syndrome, that comprehends both, has never been described, likely because the IAB is often overlooked and undiagnosed. This case could improve the awareness of IAB and of the Bayés syndrome in hemodialysis population.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial arrhythmias; atrial fibrillation; basic; clinical; electrophysiology

Mesh:

Year:  2016        PMID: 27061225      PMCID: PMC6931728          DOI: 10.1111/anec.12353

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  8 in total

1.  Prevalence and determinants of interatrial block in hemodialysis patients.

Authors:  Marco Marano; Anna D'Amato; Giuseppe Tomasino; Francesco Izzo; Marco Capasso; Eugenio Auletta
Journal:  Int Urol Nephrol       Date:  2015-01-21       Impact factor: 2.370

Review 2.  Advanced interatrial block as a substrate of supraventricular tachyarrhythmias: a well recognized syndrome.

Authors:  D Conde; A Baranchuk; A Bayés de Luna
Journal:  J Electrocardiol       Date:  2015-01-09       Impact factor: 1.438

3.  Insights into intradialytic atrial fibrillation onset mechanisms.

Authors:  Simonetta Genovesi; Antonio Vincenti; Stefano Severi
Journal:  Heart       Date:  2014-06-10       Impact factor: 5.994

4.  Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients.

Authors:  Simonetta Genovesi; Daniela Pogliani; Andrea Faini; Maria G Valsecchi; Alessandra Riva; Francesca Stefani; Irene Acquistapace; Andrea Stella; Giuseppe Bonforte; Amedeo DeVecchi; Vincenzo DeCristofaro; Gherardo Buccianti; Antonio Vincenti
Journal:  Am J Kidney Dis       Date:  2005-11       Impact factor: 8.860

5.  The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients.

Authors:  M S Buiten; M K de Bie; J I Rotmans; B A Gabreëls; W van Dorp; R Wolterbeek; S A Trines; M J Schalij; J W Jukema; T J Rabelink; L van Erven
Journal:  Heart       Date:  2014-03-26       Impact factor: 5.994

6.  Temporal distribution of arrhythmic events in chronic kidney disease: Highest incidence in the long interdialytic period.

Authors:  Michael C G Wong; Jonathan M Kalman; Eugenia Pedagogos; Nigel Toussaint; Jitendra K Vohra; Paul B Sparks; Prashanthan Sanders; Peter M Kistler; Karen Halloran; Geoffrey Lee; Stephen A Joseph; Joseph B Morton
Journal:  Heart Rhythm       Date:  2015-06-22       Impact factor: 6.343

7.  Interatrial blocks. A separate entity from left atrial enlargement: a consensus report.

Authors:  Antonio Bayés de Luna; Pyotr Platonov; Francisco G Cosio; Iwona Cygankiewicz; Carlos Pastore; Rafa Baranowski; Antoni Bayés-Genis; Josep Guindo; Xavier Viñolas; Javier Garcia-Niebla; Raimundo Barbosa; Shlomo Stern; David Spodick
Journal:  J Electrocardiol       Date:  2012-09       Impact factor: 1.438

8.  Electrocardiographic P-wave characteristics in patients with end-stage renal disease: P-index and interatrial block.

Authors:  Yalcin Solak; Enes Elvin Gul; Mehmet Kayrak; Huseyin Atalay; Turyan Abdulhalikov; Suleyman Turk; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2012-05-12       Impact factor: 2.370

  8 in total
  1 in total

1.  Progressive interatrial block associated with atrial fibrillation in a patient with hypertrophic cardiomyopathy.

Authors:  Samantha Britton; Raimundo Barbosa-Barros; Bryce Alexander; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-09-11       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.